Vontobel Holding Ltd. Biogen Inc. Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 11,153 shares of BIIB stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,153

Previous 13,805 19.21%

Holding current value

$1.76 Million

Previous $3.2 Million 32.47%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$189.07 - $236.8 $501,413 - $627,993	-2,652 Reduced 19.21%	11,153 $2.16 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $967,079 - $1.2 Million	-5,076 Reduced 26.88%	13,805 $3.2 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $3.91 Million - $4.94 Million	-18,456 Reduced 49.43%	18,881 $4.07 Million
Q4 2023 Jun 03, 2024	BUY	$222.59 - $267.94 $1.89 Million - $2.28 Million	8,499 Added 58.89%	22,930 $5.93 Million
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $4.01 Million - $4.82 Million	18,005 Added 93.14%	37,337 $9.66 Million
Q3 2023 Jun 03, 2024	SELL	$253.3 - $285.89 $288,762 - $325,914	-1,140 Reduced 7.32%	14,431 $3.71 Million
Q3 2023 Oct 10, 2023	SELL	$253.3 - $285.89 $553,713 - $624,955	-2,186 Reduced 10.16%	19,332 $4.97 Million
Q2 2023 Jun 03, 2024	BUY	$275.25 - $318.06 $1.24 Million - $1.43 Million	4,488 Added 40.49%	15,571 $4.44 Million
Q2 2023 Jul 24, 2023	BUY	$275.25 - $318.06 $1.59 Million - $1.84 Million	5,782 Added 36.74%	21,518 $6.13 Million
Q1 2023 Jun 03, 2024	SELL	$256.56 - $292.34 $2 Million - $2.28 Million	-7,798 Reduced 41.3%	11,083 $3.08 Million
Q1 2023 Apr 12, 2023	BUY	$256.56 - $292.34 $1.84 Million - $2.09 Million	7,164 Added 83.57%	15,736 $4.38 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $833,304 - $1.01 Million	-3,301 Reduced 27.8%	8,572 $2.37 Million
Q3 2022 Nov 04, 2022	BUY	$194.69 - $268.46 $65,999 - $91,007	339 Added 2.94%	11,873 $3.14 Million
Q2 2022 Jul 27, 2022	SELL	$187.54 - $223.02 $470,912 - $560,003	-2,511 Reduced 17.88%	11,534 $2.37 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $4.3 Million - $5.42 Million	-22,209 Reduced 61.26%	14,045 $2.97 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.55 Million - $3.27 Million	-11,370 Reduced 23.87%	36,254 $8.7 Million
Q3 2021 Oct 29, 2021	BUY	$282.99 - $369.05 $1.32 Million - $1.72 Million	4,657 Added 10.84%	47,624 $13.5 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $9.91 Million - $15.9 Million	-38,279 Reduced 47.11%	42,967 $14.9 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $1.65 Million - $1.94 Million	-6,810 Reduced 7.73%	81,246 $22.7 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $20.8 Million - $31.3 Million	88,056 New	88,056 $23.7 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Biogen Inc. Transaction History